ARCHIVES

BMS, Exelixis To Collaborate On Drug Development.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Shubik Group Finishes Criteria, Presents Final Draft To Rauscher

July 2, 1976

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components

February 12, 1982

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

In Turnaround, NCAB To Advise Screening Mammography for Women In Their Forties

March 28, 1997